Brief: Nextcell Pharma Q1 Operating Income Rises To SEK 1.34 Mln
27/01/2022 07:18
Jan 27 (Reuters) - NextCell Pharma AB NXTCL.ST :
* NEXTCELL PHARMA PUBLISHES INTERIM REPORT 1 2021/2022
* Q1 OPERATING INCOME AMOUNTED TO TSEK 1 347 (1 148)
* Q1 OPERATING RESULT AMOUNTED TO TSEK -6 472 (-5 473)
Source text for Eikon: ID:nWkr1Pg5MJ
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln